Ghost Tree Capital, LLC Portfolio Holdings

Ghost Tree Capital, LLC

  • $267 Million
  • Q3 2024

Ghost Tree Capital, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $267 Million distributed in 54 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Sarepta Therapeutics, Inc. with a value of $15M, Novo Nordisk A S with a value of $13.1M, Blueprint Medicines Corp with a value of $12.9M, Axsome Therapeutics, Inc. with a value of $12.1M, and Tarsus Pharmaceuticals, Inc. with a value of $11.5M.

Examining the 13F form we can see an increase of $21.8M in the current position value, from $245M to 267M.

Ghost Tree Capital, LLC is based out at New York, NY

Below you can find more details about Ghost Tree Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $267 Million
Healthcare: $237 Million
ETFs: $29.6 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$244B
$13.1 Million 4.91% of portfolio
110,000
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 54
  • Current Value $267 Million
  • Prior Value $245 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 10 stocks
  • Additional Purchases 16 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 22 stocks
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email